Table of Contents

2019-2024 Global Outsourcing in Drug Development Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Outsourcing in Drug Development Market Size 2014-2024
  • 2.1.2 Outsourcing in Drug Development Market Size CAGR by Region
• 2.2 Outsourcing in Drug Development Segment by Type
  • 2.2.1 Clinical Trials
  • 2.2.2 New Drug Application
• 2.3 Outsourcing in Drug Development Market Size by Type
  • 2.3.1 Global Outsourcing in Drug Development Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Outsourcing in Drug Development Market Size Growth Rate by Type (2014-2019)
• 2.4 Outsourcing in Drug Development Segment by Application
  • 2.4.1 Pharmaceutical Industries
  • 2.4.2 Biotechnology Industries
  • 2.4.3 Medical Device Industries
• 2.5 Outsourcing in Drug Development Market Size by Application
  • 2.5.1 Global Outsourcing in Drug Development Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Outsourcing in Drug Development Market Size Growth Rate by Application (2014-2019)

3 Global Outsourcing in Drug Development by Players

• 3.1 Global Outsourcing in Drug Development Market Size Market Share by Players
  • 3.1.1 Global Outsourcing in Drug Development Market Size by Players (2017-2019)
  • 3.1.2 Global Outsourcing in Drug Development Market Size Market Share by Players (2017-2019)
• 3.2 Global Outsourcing in Drug Development Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Outsourcing in Drug Development by Regions

• 4.1 Outsourcing in Drug Development Market Size by Regions
• 4.2 Americas Outsourcing in Drug Development Market Size Growth
• 4.3 APAC Outsourcing in Drug Development Market Size Growth
• 4.4 Europe Outsourcing in Drug Development Market Size Growth
• 4.5 Middle East & Africa Outsourcing in Drug Development Market Size Growth

5 Americas

• 5.1 Americas Outsourcing in Drug Development Market Size by Countries
• 5.2 Americas Outsourcing in Drug Development Market Size by Type
• 5.3 Americas Outsourcing in Drug Development Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Outsourcing in Drug Development Market Size by Countries
• 6.2 APAC Outsourcing in Drug Development Market Size by Type
• 6.3 APAC Outsourcing in Drug Development Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Outsourcing in Drug Development by Countries
• 7.2 Europe Outsourcing in Drug Development Market Size by Type
• 7.3 Europe Outsourcing in Drug Development Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Outsourcing in Drug Development by Countries
• 8.2 Middle East & Africa Outsourcing in Drug Development Market Size by Type
• 8.3 Middle East & Africa Outsourcing in Drug Development Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Outsourcing in Drug Development Market Forecast

• 10.1 Global Outsourcing in Drug Development Market Size Forecast (2019-2024)
• 10.2 Global Outsourcing in Drug Development Forecast by Regions
  • 10.2.1 Global Outsourcing in Drug Development Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Outsourcing in Drug Development Forecast by Type
• 10.8 Global Outsourcing in Drug Development Forecast by Application

11 Key Players Analysis

• 11.1 Charles River Laboratories
  • 11.1.1 Company Details
  • 11.1.2 Outsourcing in Drug Development Product Offered
  • 11.1.3 Charles River Laboratories Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Charles River Laboratories News
• 11.2 Covance
  • 11.2.1 Company Details
  • 11.2.2 Outsourcing in Drug Development Product Offered
  • 11.2.3 Covance Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Covance News
• 11.3 ICON
  • 11.3.1 Company Details
  • 11.3.2 Outsourcing in Drug Development Product Offered
  • 11.3.3 ICON Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 ICON News
• 11.4 Parexel
  • 11.4.1 Company Details
  • 11.4.2 Outsourcing in Drug Development Product Offered
  • 11.4.3 Parexel Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Parexel News
• 11.5 Quintiles Transnational
  • 11.5.1 Company Details
  • 11.5.2 Outsourcing in Drug Development Product Offered
  • 11.5.3 Quintiles Transnational Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Quintiles Transnational News
• 11.6 PPD
  • 11.6.1 Company Details
  • 11.6.2 Outsourcing in Drug Development Product Offered
  • 11.6.3 PPD Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 PPD News
• 11.7 PRA Health Sciences
  • 11.7.1 Company Details
  • 11.7.2 Outsourcing in Drug Development Product Offered
  • 11.7.3 PRA Health Sciences Outsourcing in Drug Development Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 PRA Health Sciences News

...

12 Research Findings and Conclusion

For a biopharmaceutical industry in flux, outsourcing services are playing a greater and more diverse role in drug development.

According to this study, over the next five years the Outsourcing in Drug Development market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Outsourcing in Drug Development business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Outsourcing in Drug Development market by product type, application, key companies and key regions.

This study considers the Outsourcing in Drug Development value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Clinical Trials
New Drug Application
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Pharmaceutical Industries
Biotechnology Industries
Medical Device Industries

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Charles River Laboratories
Covance
ICON
Parexel
Quintiles Transnational
PPD
PRA Health Sciences
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Outsourcing in Drug Development market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Outsourcing in Drug Development market by identifying its various subsegments.
Focuses on the key global Outsourcing in Drug Development players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Outsourcing in Drug Development with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Outsourcing in Drug Development submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.